Overall verdict
Neutral
5.1/10
1-year performance
+27.33%
Score breakdown
Up 27.3% over 1 year, 96% of the 52-week range.
Strongest: Financial strength 6.6/10. Weakest: Valuation 3.7/10.
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors ; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas.
It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions ; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples ;
DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food ; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.
Sector
Materials
Industry
Chemicals
Primary listing
Mil
Italy
CEO
Aldo Romario
Founded
1927
Employees
7 623
Revenue / employee
239 611 EUR
Next earnings
November 13, 2026 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
64.30 EUR
52-week low
44.85 EUR
1-year performance
27.33%
Rising
Year-to-date performance
28.61%
Rising
Drawdown
-1.09%
Near its high
Position in the 52-week range
96% of range
Against the world ETF
Over 22 years, from April 2005 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned much more, but shaking 1.6 times harder: once that risk is counted, it did about as well as the ETF.
10 000 € placed at the end of April 2005 are worth today
| SOL | 134 685 € |
| World ETF | 72 974 € |
| STOXX Europe 600 | 46 112 € |
| Risk-free placement | 13 105 € |
The risk
- Shaking:the share moves 1.6 times as much as the world ETF.
- Worst fall:-52 % between May 2007 and December 2008. 10 000 € placed at the top fell to 4 816 €. The world ETF, at worst: -49 %. Back to its high in 28 months.
SOL earned more than the world ETF since 2005
Value of 10 000 € placed at the end of April 2005, dividends reinvested, in euros
- SOL: 134 685 €
- World ETF: 72 974 €
- STOXX Europe 600: 46 112 €
- Risk-free placement: 13 105 €
Share price without dividends; the world ETF and the index reinvest theirs. A dividend payer is therefore understated here.
Based on past performance. This is not a recommendation.
Range: 60.00 EUR - 66.00 EUR (2 methods agree)
The price implies growth of 23.26% per year; the company grows at 10.14%.
Gross margin 16.9%, net margin 9.4%, ROIC 9.6%, ROE 15.5%.
Net margin
9.37%
Fair
Sector 10.49%|S&P 13.40%
Gross margin
16.90%
Low
Return on equity (ROE)
15.45%
Exceptional
Sector 9.93%|S&P 17.06%
Return on invested capital (ROIC)
9.56%
High
Free cash flow margin (FCF)
3.91%
Fair
Profit-to-cash conversion (FCF conversion)
0.42x
Fair
Margin stability
0.5 pts
Very steady
Revenue to net income
Growth
5.2/10Revenue up 9.4% over 1 year, 12.8% a year over 5, EPS 10.1% a year over 5.
Revenue (trailing 12 months)
1.9Md EUR
Revenue growth (1y)
9.40%
Solid
Revenue growth (3y)
28.78%
Solid
EPS growth (1y)
13.06%
Solid
EPS CAGR (5y)
10.14%
Exceptional
EPS revisions (3 months)
-1.06%
Revised down
Valuation
3.7/10P/E 33.3x, forward P/E 31.7x, EV/EBITDA 14.7x, PEG 3.28. The multiple sits in the 100th percentile of its own 5-year history.
P/E (TTM)
33.3x
Cheap
Sector 72.2x|S&P 23.6x
Forward P/E
31.7x
Expensive
EV / EBITDA
14.7x
Fair
Sector 15.3x|S&P 15.5x
PEG
3.28
Very expensive
Sector 0.55|S&P 0.91
Fair value (reverse DCF)
62.75 EUR
Fairly priced
P/E vs its own 5-year history
among the 1% highest valuations
At its historical high
Market cap
5.8Md EUR
Financial strength
6.6/10Cash covers 36.0% of the debt, net debt/EBITDA 1.2x.
Net debt / EBITDA
1.2x
Solid
Gearing (net debt / equity)
44.03%
Solid
Cash
298M EUR
Cash / market cap
5.16%
Tight
Cash / total debt
35.97%
Solid
Interest coverage
8.6x
Solid
Net debt
530M EUR
Equity
1.2Md EUR
Closed daily candles, 2 years
Last close on November 11, 2026: 63.60 EUR
- MM2059.64
- MM5057.36
- MM20056.20
- RSI 1466.9
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+2.12%
200-day average slope, 3 months
+4.61%
50-day average slope, 1 month
+3.85%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.57 % per day
Volatility change
-1.89%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 2.01 (3) | 2.04 (4) | 1 944 (4) | 506 (4) | 193 (1) |
| 2027 | 2.28 (3) | 2.29 (4) | 2 099 (4) | 547 (4) | 227 (1) |
Amounts in millions of EUR, EPS in EUR per share. In brackets, the number of analysts. Consensus as of November 3, 2026.
Same sub-industry: 20 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LIN | 6.5 | 6.0 | 242Md USD | 35.0x | 19.3 % | 9.2 % | 12.0 % | 1.8x | 2.1 % | 28.1 % | ||
| 2 | 4091 | 6.5 | 6.9 | 16.1Md USD | 18.0x | 10.1 % | 11.7 % | 7.8 % | 2.4x | 5.8 % | 21.7 % | ||
| 3 | 002430 | 6.1 | 5.5 | 3.9Md USD | 21.2x | 6.9 % | 16.4 % | 7.5 % | 2.0x | 4.7 % | -8.0 % | ||
| 4 | AI | 5.3 | 4.4 | 134Md USD | 34.6x | 13.1 % | -0.4 % | 9.7 % | 1.2x | 1.3 % | 24.0 % | ||
| 5 | 688146 | 5.1 | 5.2 | 9.5Md USD | 114.2x | 20.2 % | 114.9 % | 11.7 % | -3.8x | 0.1 % | 273.0 % | ||
| 6 | SOL | 5.1 | 5.4 | 6.4Md USD | 33.3x | 9.4 % | 9.4 % | 9.6 % | 1.2x | 1.3 % | 27.3 % | ||
| 7 | 523457 | 4.4 | 4.1 | 6.2Md USD | 117.5x | 18.1 % | 12.3 % | 10.5 % | -0.0x | — | 17.0 % | ||
| 8 | APD | 4.2 | 2.7 | 70.2Md USD | 132.3x | 4.1 % | 12.3 % | 1.7 % | 3.6x | 0.7 % | 21.5 % | ||
| 9 | 4088 | 4.0 | 3.6 | 4.0Md USD | Not meaningful (loss) | -5.7 % | 10.3 % | -8.0 % | 4.5x | 5.8 % | 23.8 % |
